Artificial intelligence (AI) and machine learning technologies continue to transform biotech and healthcare. Novel AI models enhance accuracy in lung lesion bronchoscopy and medical diagnosis coding, improving clinical decisions. At the Arc Institute, 'Germinal' platform integrates protein structure prediction and antibody language models for efficient antibody design, reducing experimental burden. AI-driven systems autonomously optimize drug prescriptions to prevent graft-versus-host disease. Additionally, quantum computing breakthroughs accelerate complex data analysis, setting the stage for faster biomedical discovery. These advances underscore AI’s expanding role in precision medicine and drug development efficiency.